Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004838022 | SCV005462423 | uncertain significance | not specified | 2024-10-29 | criteria provided, single submitter | clinical testing | The c.682G>C (p.A228P) alteration is located in exon 2 (coding exon 2) of the NPC1L1 gene. This alteration results from a G to C substitution at nucleotide position 682, causing the alanine (A) at amino acid position 228 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |